Publication | Open Access

Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

MedicineMetronomic TherapyPathologyBronchial NeoplasmSequential Alk InhibitorsMulticentric Real-world StudyCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyBrigalk Study